Health Biotech Ltd
Send Inquiry Send SMS
Health Biotech Ltd  Banner
Home » Products » Pharmaceutical Contract Manufacturing Services » Biopharmaceutical Development & Research Manufacturing

Biopharmaceutical Development & Research Manufacturing

Biopharmaceutical Development & Research Manufacturing
Biopharmaceutical Development & Research Manufacturing
Send Inquiry
Product Code : 02
Product Description
Health Biotech Research Centre's (HBRC's) scientists use Quality-By-Design (QbD) tools at early as well as late stages of formulation development. Use of Design of experiments (DOE) along with risk assessment strategies helps us to design our experimental plan which is scientifically valid and targeted for completion within our delivery timelines.

Contract Process Development Services :
  • Process Development for small molecule, injectables and biologics
  • Laboratory scale, pilot scale, cGMP clinical trial materials and cGMP commercial scale
  • Process optimization,Technology transfers
  • Formulation development for injectable andlyophilized products (clinical to commercial)
  • Process development, optimization and upstream / downstream processing
  • Lab & pilot scale process development
  • Test batches manufacturing for stability studies, test and analysis
  • Clinical packaging & labeling
HBRC has team of expert scientist with rich experience inbiotechnology, pharmaceuticals andnanobiotechnology,synchronized for successful development of technology and finish formulations. HBRC's scientists have extensive multinational expertise developing formulations for conventional and specialized dosage forms, including sustained (SR) & modified release (MR) solids, liquids, and injectables. Pharmaceutical finished formulation are developed keeping in view product stability, compatibility and patient compliance in custamarized way following Quality by Design (QBD) approach. All of the formulation are designed and developed for techno-economical feasibility and commercialization success. Before prototype development exhaustive pre-formulation studies are performed for characterization of the Active Pharmaceutical Ingredient (API) with excipients.

Quality by Design (QBD) Program
  • Define Target Product Profile (TPP)
  • Critical Quality Attributes (CQAs) are determined
  • Extensive theoretical and literature survey
  • Risk assessment
  • Control strategy for sensitive products (moisture/oxidation)
  • Lyophilization cycle (recipie) standardization
Analytical Services:-
  • Analytical method development, optimization, validation and comparability studies
  • Reference standard establishment and storage
  • Stability management
  • Product characterization
  • Impurity profiling and related forced degradation studies
Analytical capabilities(Product Related Impurities) :-
  • Charge related impurities- by Ion exchange chromatography and zeta potential
  • Size related impurities- by SEC and Non-reducing SDS-PAGE
  • Degraded protein- by reducing SDS-PAGE
  • Oxidized and reduced impurities- by RP-HPLC
  • Functional group analysis by NMR and FTIR
Microbiology related analysis:-
  • Bio-burden
  • Sterility
  • BET
  • MIC
  • MBC
  • Time kill curve
HBRC's experienced project managers are pharmaceutical scientists, life scientist and biotechnologist. In coordination with manufacturing staff they are capable of ensuring your project timelines and expectations. They takes the lead on your development project, from pre-formulation, drug formulation development to clinical trial material (CTM) manufacture keeping you informed every step of the way.

Health Biotech Ltd.

HEALTH BIOTECH LTD. All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.